Back to Invesco Ltd. Invesco Ltd.

NKTRNKTR
23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Nektar Therapeutics

Invesco Ltd. holds 79,856 shares of NKTR (Nektar Therapeutics), worth $5.6M as of 2026-Q2. The position was decreased (-85.9% shares). NKTR represents 0.0% of Invesco Ltd.'s portfolio.

Current Value

$5.6M

Current Shares

79,856

Total Value Change

-$597.2M

Total Shares Change

-35.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
79,856
-85.9%
$5.6M0.0%$69.81
0
2026-Q1
Increased
567,458
+21.2%
$40.8M0.0%$68.11
35
2025-Q4
Increased
468,159
+106.3%
$19.8M0.0%$41.90
46
2025-Q3
Increased
226,897
+608.3%
$12.9M0.0%$58.92
45
2025-Q2
Decreased
32,032
-94.9%
$827,6840.0%$25.76
0
2025-Q1
Decreased
623,218
-4.9%
$423,7880.0%$11.10
0
2024-Q4
Increased
655,526
+1.4%
$609,6390.0%$14.10
25
2024-Q3
Increased
646,808
+0.4%
$840,8500.0%$17.55
25
2024-Q2
Increased
644,226
+22.4%
$798,8400.0%$18.60
30
2024-Q1
Increased
526,343
+73.2%
$491,7100.0%$13.95
36
2023-Q4
Decreased
303,901
-15.4%
$171,7040.0%$8.40
0
2023-Q3
Decreased
359,347
-93.5%
$214,0270.0%$9.00
0
2023-Q2
Decreased
5.5M
-85.2%
$3.2M0.0%$8.70
0
2023-Q1
Increased
37.5M
+0.4%
$26.3M0.0%$9.60
29
2022-Q4
Increased
37.3M
+0.2%
$84.4M0.0%$33.90
30
2022-Q3
Increased
37.3M
+0.1%
$119.2M0.0%$45.60
30
2022-Q2
Decreased
37.2M
0.0%
$141.5M0.0%$59.40
0
2022-Q1
Increased
37.2M
+0.9%
$200.7M0.1%$83.55
31
2021-Q4
Increased
36.9M
+3.4%
$498.4M0.1%$210.00
39
2021-Q3
Increased
35.7M
+0.0%
$640.7M0.2%$268.95
38
2021-Q2
Increased
35.7M
+0.6%
$611.9M0.2%$261.15
38
2021-Q1
Decreased
35.4M
-0.0%
$709M0.2%$292.65
0
2020-Q4
New
35.5M
-
$602.8M0.2%$269.10
52

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used